_3604577.png)
_2490489.png)
Evidence Generation & Validation
Local clinical evidence, analytical validation, and performance verification studies for medical devices and IVD in Tanzania—supporting regulatory submissions and market access.
Service Overview
Labmark designs and executes evidence generation studies for manufacturers entering the Tanzania market. Whether you need local clinical performance data, analytical validation against regional sample matrices, or post-market evidence, we provide end-to-end study support.
Our Expertise
Over 10 years of clinical research experience across infectious disease diagnostics, cardiovascular, neurology, and orthopedics—with deep expertise in ICH-GCP, ISO 14155, and IVDR/MDR compliance.
When You Need This
- Regulatory submission requires local performance data
- TMDA requests Tanzania-specific clinical evidence
- Validating assay performance with regional sample types
- Post-market surveillance or tender support requirements
- Bridging studies from CE/FDA data to local context
Study Types We Support
Clinical Performance Studies
- Prospective clinical trials
- Diagnostic accuracy studies
- Usability and human factors studies
- Comparative effectiveness research
Analytical Validation
- Method verification and validation
- Precision and accuracy studies
- Interference and cross-reactivity testing
- Stability and robustness evaluation
Performance Verification
- Lot-to-lot consistency testing
- Reference range establishment
- Method comparison studies
- Equivalence and bridging studies
Post-Market Evidence
- Real-world performance monitoring
- Post-market clinical follow-up (PMCF)
- Surveillance data collection
- Outcome and effectiveness studies
Sample & Specimen Services
- Characterized sample procurement
- Biobank access coordination
- Prospective sample collection
- Sample handling and logistics
Regulatory-Aligned Studies
- TMDA submission support studies
- CE-IVDR performance evaluation
- FDA 510(k) clinical data
- WHO prequalification studies
What You Receive
Study Protocol
Scientifically rigorous, regulatory-aligned protocol designed for your specific objectives and submission requirements.
Ethics & Approvals
IRB/IEC submission support, TMDA clinical trial authorization, and site agreement coordination.
Data Management
GCP-compliant data collection, cleaning, and management with full audit trail and quality controls.
Statistical Analysis
Pre-specified analysis plan, statistical programming, and interpretation aligned with regulatory expectations.
Clinical Study Report
Comprehensive CSR formatted for regulatory submission—TMDA, CE, FDA, or WHO prequalification.
Site & Investigator Support
Site selection, investigator training, monitoring visits, and ongoing study coordination.
Our Capabilities
Site Network
Established relationships with clinical sites across Tanzania, including tertiary hospitals, regional facilities, and specialized diagnostic centers.
Laboratory Access
Coordination with accredited laboratories for analytical work, sample processing, and reference testing.
Infectious Disease Focus
Deep experience in HIV, TB, malaria, hepatitis, and emerging infectious disease diagnostics—matching Tanzania's disease burden priorities.
Quality Standards
All studies conducted per ICH-GCP, ISO 14155, and applicable regulatory standards with robust quality oversight.
National Health Priorities
Tanzania's health priorities—including infectious disease control, maternal health, and NCD management—create opportunities for evidence generation that aligns with both regulatory requirements and local health system needs.
Related Services
Evidence generation often connects with other market entry activities:
TMDA Regulatory Support
Connect your evidence package with regulatory pathway planning and submission support.
Learn more →Partner Identification
Find distribution or manufacturing partners who can support ongoing evidence needs.
Learn more →QMS Readiness
Ensure quality systems support evidence generation and ongoing compliance requirements.
Learn more →Ready to Generate Local Evidence?
Schedule a 15-minute call to discuss your evidence requirements and how Labmark can design and execute the right study for your needs.
Discuss Your Study Needs